FDA says U.S. youth e-cigarette prevention campaign reduced vaping rates

Mar.17.2025
FDA says U.S. youth e-cigarette prevention campaign reduced vaping rates
FDA successfully prevented 444,252 American teens from using e-cigarettes, reducing use to lowest levels in a decade.

Key highlights:

 

1. Preventing youth vaping: The U.S. Food and Drug Administration (FDA)-led 'The Real Cost' youth e-cigarette prevention campaign successfully deterred approximately 444,252 American adolescents (aged 11 to 17 at the time of recruitment) from starting to use e-cigarettes between 2023 and 2024.

 

2. Youth e-cigarette use declines: According to data from the U.S. National Youth Tobacco Survey, the number of middle and high school students currently using e-cigarettes fell from 5.38 million in 2019 to 1.63 million in 2024, reaching the lowest level in a decade.

 

3. Diverse marketing strategies and creative advertising: 'The Real Cost' youth e-cigarette prevention campaign employed multiple marketing strategies and creative ads, delivering messages to adolescents through youth-oriented communication channels, including digital and streaming platforms, social media, and gaming platforms.

 

4. Collaborating with federal partners: The FDA also collaborates with federal partners to ensure that those who manufacture, distribute, or sell illegal tobacco products are subject to legal sanctions.

 


 

2Firsts, reporting from Shenzhen - On March 14, 2025, the FDA announced that its "The Real Cost" youth e-cigarette prevention campaign successfully prevented approximately 444,252 American adolescents (recruited at ages 11 to 17) from starting to use e-cigarettes between 2023 and 2024. 

 

The campaign was launched in 2018 under the leadership of President Trump and the results were published in the peer-reviewed scientific journal, the American Journal of Preventive Medicine.

 

According to data from the National Youth Tobacco Survey, the number of middle and high school students currently using e-cigarettes in the United States has decreased from 5.38 million in 2019 to 1.63 million in 2024, reaching the lowest level in a decade. 

 

This assessment tracked a nationally representative sample of American youth and found that watching "The Real Cost" advertisements reduced the likelihood of teenagers who had never used e-cigarettes starting to use them.

 

In addition, adolescence is a critical period for preventing tobacco product use, as the majority of adult tobacco users began using during their teenage years. Dr. Brian King, director of the FDA's Center for Tobacco Products, pointed out that youth tobacco prevention efforts are not only effective, but also a cost-effective way to protect young people from lifelong effects of nicotine addiction.

 

The Real Cost" youth e-cigarette prevention campaign employs various marketing strategies and creative advertisements to communicate with teenagers through channels like digital and streaming platforms, social media, and gaming platforms. These educational efforts are part of the organization's strategy to reduce and prevent youth tobacco product use. 

 

The FDA also collaborates with federal partners to ensure that those who manufacture, distribute, or sell illegal tobacco products are legally punished.

 

Previous research has shown that the "The Real Cost" campaign is a cost-effective strategy by reducing the lifetime risk of tobacco-related diseases and death. 

 

The campaign is also effective in reducing smoking-related losses such as premature death, expensive medical care, wage losses, decreased productivity, and increased disability, saving $180 for every $1 invested.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
Philip Morris Japan launched its fourth confirmed nationwide convenience-store discount campaign for IQOS ILUMA i devices in 2026 on October 26, cutting three models by as much as ¥2,000, or about $12.70. The campaign began one day after JT ended a promotion that reduced Ploom AURA to ¥1,480, or about $9.40. JT says Ploom's share of Japan's heated-products category rose from 10.9% in January 2024 to 18.3% in June 2026, a gain of 7.4 percentage points, while PMI says IQOS still held about 68% category share in the third quarter. At the same time, Japan's two-stage heated-tobacco tax adjustment has pushed stick prices higher, leaving device discounts as an increasingly important tool for lowering the upfront cost of customer acquisition.
Market
Oct.28
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
Combined tobacco and vaping sales in UK convenience stores fell 10.6% year over year in the first half of 2026, making the category a major drag on channel performance, according to retail research organization IGD. Total convenience sales declined 1.2%, while sales excluding tobacco and vaping increased 0.7%. IGD's 2026 category-share figures show tobacco and vaping accounting for 15.4% of convenience sales, compared with 15.1% for alcohol. The organization forecasts alcohol could overtake tobacco and vaping as the largest category by sales value as early as 2027 if current trends continue. IGD expects the convenience market to increase from £48.6 billion in 2026 to £54.9 billion in 2031, a 2.5% compound annual growth rate, or 3.4% excluding tobacco and vaping.
DATA
Nov.11
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Russia has placed shares in four Japan Tobacco International businesses under temporary management, the first such move involving a major global tobacco manufacturer, according to Interfax. JTI held 35.8% of Russia's tobacco market by volume in the first nine months of 2026. While British American Tobacco and Imperial Brands have exited Russia, Philip Morris International continues operating there. As the market changes and diplomatic efforts continue, could international tobacco companies that left Russia eventually return?
Nov.06